Related Experiment Video
Updated: Feb 2, 2026

The Preparation of Primary Hematopoietic Cell Cultures From Murine Bone Marrow for Electroporation
Published on: January 6, 2009
Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting as Transverse Myelitis
Lauren Shea1, Yan Zhao2, Vishnu Reddy3
1Departments of Internal Medicine.
Insights
Primary bone marrow diffuse large B-cell lymphoma (BM-DLBCL) is a rare cancer. This study reviews 107 cases, finding it presents with cytopenias, a non-germinal center phenotype, and aggressive disease with poor survival.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Primary bone marrow diffuse large B-cell lymphoma (BM-DLBCL) is an uncommon non-Hodgkin lymphoma.
- Prior reports are limited, necessitating further characterization of this rare entity.
Observation:
- A case of BM-DLBCL presenting with neurologic deficits mimicking acute transverse myelitis is detailed.
- A literature review of 107 BM-DLBCL cases was conducted.
Findings:
- BM-DLBCL frequently presents with cytopenias and B symptoms.
- A predominant non-germinal center phenotype is characteristic of BM-DLBCL.
- The disease exhibits aggressive behavior, indicated by high International Prognostic Index scores and a median survival of 10.0 months.
Implications:
- Understanding BM-DLBCL presentation and characteristics is crucial for timely diagnosis and management.
- The aggressive nature necessitates prompt and effective therapeutic strategies.
- Further research into optimal treatment protocols for BM-DLBCL is warranted.
Abstract:
Primary bone marrow diffuse large B-cell lymphoma (BM-DLBCL) is uncommon, with prior reports largely limited to small case series. Here we report the case of a patient who presented with neurologic deficits consistent with acute transverse myelitis and was found to have DLBCL isolated to the bone marrow. We follow this case with a review of the literature summarizing 107 reported cases of BM-DLBCL. Consistent with our case, literature review indicates that BM-DLBCL is characterized by (1) frequent presentation with cytopenias and B symptoms (2) predominant non-germinal center phenotype and (3) aggressive disease with high International Prognostic Index score and low overall survival, with a median survival of 10.0 months in our cohort.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Diffusion
Diffusion
Speed of a Transverse Wave
One of the key properties of any wave is the wave speed. Light...
Deformations in a Transverse Cross Section
As the material stretches, it expands or contracts in orthogonal directions to the load. This phenomenon varies...
Bone Cells and Tissue
Osteoblasts and Osteocytes
The osteoblast is the bone cell responsible for forming new bone tissue. It is found in the growing portions of bone, including the...

